HCSG - Healthcare Services Group, Inc.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Bensalem,
United States
Type: Equity
HCSG price evolution
HCSG
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $29.55 | $53.98 | $54.33 | |
| Short term investments | $101.16 | $75.62 | $93.13 | |
| Net receivables | $406.5 | $398.88 | $407.14 | $383.51 |
| Inventory | $17.05 | $17.86 | $18.04 | $18.48 |
| Total current assets | $578.12 | $573.21 | $580.41 | $571.7 |
| Long term investments | $20.87 | $23.29 | $24.83 | |
| Property, plant & equipment | $28.43 | $29.84 | $29.19 | $28.77 |
| Goodwill & intangible assets | $86.31 | $86.98 | $87.66 | |
| Total noncurrent assets | $226.49 | $223.47 | $218.96 | |
| Total investments | $122.03 | $98.91 | $117.96 | |
| Total assets | $805.84 | $799.7 | $803.88 | $790.65 |
| Current liabilities | ||||
| Accounts payable | $76.64 | $72.22 | $72.92 | $83.22 |
| Deferred revenue | ||||
| Short long term debt | $30 | $40 | $25 | |
| Total current liabilities | $197.2 | $209.48 | $209.38 | $216.93 |
| Long term debt | $10.66 | $10.59 | $11.23 | |
| Total noncurrent liabilities | $118.8 | $119.92 | $117.11 | |
| Total debt | $40.66 | $50.59 | $36.23 | |
| Total liabilities | $317.09 | $328.28 | $329.3 | $334.04 |
| Shareholders' equity | ||||
| Retained earnings | $212.63 | $198.59 | $200.38 | $185.01 |
| Other shareholder equity | $488.75 | -$2.62 | -$2.17 | -$1.84 |
| Total shareholder equity | $471.42 | $474.58 | $456.62 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $54.33 | $26.28 | $70.79 | $139.33 |
| Short term investments | $93.13 | $95.2 | $114.4 | $125.01 |
| Net receivables | $383.51 | $343.41 | $293.39 | $255.47 |
| Inventory | $18.48 | $21.16 | $26.02 | $31.59 |
| Total current assets | $571.7 | $508.63 | $546.38 | $572.4 |
| Long term investments | $24.83 | $32.61 | $29.26 | $34.42 |
| Property, plant & equipment | $28.77 | $22.98 | $28.1 | $26.56 |
| Goodwill & intangible assets | $87.66 | $91.47 | $95.56 | $69.27 |
| Total noncurrent assets | $218.96 | $209.7 | $231.15 | $212.63 |
| Total investments | $117.96 | $127.81 | $143.66 | $159.43 |
| Total assets | $790.65 | $718.33 | $777.53 | $785.03 |
| Current liabilities | ||||
| Accounts payable | $83.22 | $68.3 | $64.42 | $52.24 |
| Deferred revenue | ||||
| Short long term debt | $25 | $25 | ||
| Total current liabilities | $216.93 | $178.62 | $191.13 | $162.26 |
| Long term debt | $11.23 | $8.1 | $11.3 | $11.36 |
| Total noncurrent liabilities | $117.11 | $113.54 | $133.73 | $142.31 |
| Total debt | $36.23 | $33.1 | $11.3 | $11.36 |
| Total liabilities | $334.04 | $292.16 | $324.85 | $304.57 |
| Shareholders' equity | ||||
| Retained earnings | $185.01 | $154.5 | $183.96 | $200.89 |
| Other shareholder equity | -$1.84 | -$3.48 | $4 | $5.56 |
| Total shareholder equity | $456.62 | $426.17 | $452.68 | $480.46 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $428.15 | $423.43 | $423.84 | |
| Cost of revenue | $358.91 | $350.38 | ||
| Gross Profit | $63.42 | $64.52 | $73.46 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $46.91 | $46.25 | ||
| Total operating expenses | $46.89 | $46.91 | $46.25 | |
| Operating income | $17.61 | $27.21 | ||
| Income from continuing operations | ||||
| EBIT | $23.31 | $33.1 | ||
| Income tax expense | $4.78 | $6 | $8.44 | |
| Interest expense | $2 | $2.06 | ||
| Net income | ||||
| Net income | $14.03 | $15.31 | $22.6 | |
| Income (for common shares) | $15.31 | $22.6 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1671.39 | $1690.18 | $1641.96 | $1760.3 |
| Cost of revenue | $1456.64 | $1496.34 | $1415.08 | $1492.32 |
| Gross Profit | $214.75 | $193.84 | $226.88 | $267.99 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $166.77 | $140.34 | $173.11 | $150.78 |
| Total operating expenses | $166.77 | $140.34 | $173.11 | $150.78 |
| Operating income | $47.97 | $53.5 | $53.77 | $117.21 |
| Income from continuing operations | ||||
| EBIT | $60.91 | $48.07 | $63.21 | $130.56 |
| Income tax expense | $14.67 | $10.45 | $15.96 | $30.5 |
| Interest expense | $7.86 | $2.99 | $1.39 | $1.37 |
| Net income | ||||
| Net income | $38.39 | $34.63 | $45.86 | $98.68 |
| Income (for common shares) | $38.39 | $34.63 | $45.86 | $98.68 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$1.79 | $15.31 | $22.6 | |
| Operating activities | ||||
| Depreciation | $3.68 | $3.53 | $3.78 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.11 | $2.48 | $2.19 | |
| Total cash flows from operations | $16.32 | -$26.03 | $49.45 | |
| Investing activities | ||||
| Capital expenditures | -$1.19 | -$2.17 | -$1.43 | |
| Investments | -$26.57 | $13.89 | $0.05 | |
| Total cash flows from investing | -$15.75 | -$27.75 | $11.72 | -$1.38 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$3 | -$5.04 | ||
| Net borrowings | -$10 | $15 | -$20 | |
| Total cash flows from financing | -$5.04 | -$13 | $13.97 | -$25.05 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$26.19 | -$24.44 | -$0.35 | $23.02 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $38.39 | $34.63 | $45.86 | $98.68 |
| Operating activities | ||||
| Depreciation | $14.34 | $15.32 | $14.67 | $14.27 |
| Business acquisitions & disposals | -$0.11 | -$23.88 | ||
| Stock-based compensation | $8.98 | $9.21 | $8.83 | $7.87 |
| Total cash flows from operations | $43.5 | -$8.17 | $37.11 | $217.21 |
| Investing activities | ||||
| Capital expenditures | -$5.29 | -$4.82 | -$5.48 | -$4.07 |
| Investments | $1.99 | $7.51 | $6.36 | -$32.78 |
| Total cash flows from investing | -$3.29 | $2.58 | -$22.99 | -$36.84 |
| Financing activities | ||||
| Dividends paid | -$63.37 | -$62.23 | -$60.7 | |
| Sale and purchase of stock | -$11.28 | $0.52 | -$19.02 | $3.01 |
| Net borrowings | $25 | -$10 | ||
| Total cash flows from financing | -$12.15 | -$38.93 | -$82.65 | -$68.37 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $28.05 | -$44.52 | -$68.54 | $112 |
News
Fundamentals
| Market cap | $707.41M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 73.38M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 4.07% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.73 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.93 |
| Quick ratio | 2.85 |